Ignite Creation Date:
2025-12-24 @ 4:42 PM
Ignite Modification Date:
2025-12-27 @ 11:35 AM
Study NCT ID:
NCT01095666
Status:
COMPLETED
Last Update Posted:
2017-09-11
First Post:
2010-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-26
First Submit QC Date:
None
Study First Post Date:
2010-03-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-03
Results First Submit QC Date:
None
Results First Post Date:
2017-09-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-04
Last Update Post Date:
2017-09-11
Last Update Post Date Type:
ACTUAL